MD CELL Solution (A Joint-stock Corporation GMC Holdings)
Welcome to the PulseAid listing for the MD CELL Solution drug offered from A Joint-stock Corporation GMC Holdings. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | A Joint-stock Corporation GMC Holdings |
NON-PROPRIETARY NAME: | Niacinamide, Panthenol, Salicylic Acid |
SUBSTANCE NAME: | NIACINAMIDE; PANTHENOL; SALICYLIC ACID |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2016-07-22 |
END MARKETING DATE: | 0000-00-00 |
MD CELL Solution HUMAN OTC DRUG Details:
Item Description | MD CELL Solution from A Joint-stock Corporation GMC Holdings |
LABELER NAME: | A Joint-stock Corporation GMC Holdings |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .003; .002; .00001(1/100mL; 1/100mL; 1/100mL) |
START MARKETING DATE: | 2016-07-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70834-102_4b16bd52-27f3-4f56-9aec-0148ddf62b5c |
PRODUCT NDC: | 70834-102 |
APPLICATION NUMBER: | |
Other NIACINAMIDE; PANTHENOL; SALICYLIC ACID Pharmaceutical Manufacturers / Labelers: